Download presentation
Presentation is loading. Please wait.
Published byIra Augustine Ball Modified over 9 years ago
1
March 2011 Chicago
2
IDPH Laboratory Update Rescreening Treatment Timeliness SBHC/JDC Chlamydia Screening Initiative SBHC-Sports Physical Project Special CT/GC testing initiative EPT Survey and Findings
3
Oral/Rectal Study Pooling
5
Howard Brown Clinic Clinic staff Illinois Department of Public Health John Nawrocki, Ph.D. (BD Qx Assay) Gary Boyce University of Illinois William Janda, Ph.D. (GenProbe Assay)
6
Testing positive for CT by both assays 3 oral & 7 rectal specimens Testing positive for GC by both assays 17 oral; 6 rectal
7
Objective: to determine the sensitivity of the BD Qx assay for the detection of known positive specimens (NG/CT) in pools of 4 specimens. Specimens identified as positive for either or both agents were re-tested in pools with 3 known negative specimens.
8
SpecimenType #Positive Sx tested #Positive Sx detected in pools %Sensitivity Male Urine 2727100 Female Urine 3333100 Endocervical Swab 4544*97.7 Vaginal Swab 4544*97.7 Urethral Swab 4545100 Dual positives – picked up one of the positive test results
10
Gaydos et al: CT Reinfection Rates Among Female Adolescents Seeking Rescreening AT SBHCs 236 of 897 ( 26.3% ) females students reinfected Broussard et al: Screening Adolescents in a JDC for GC/CT: Prevalence and Reinfection Rates Reinfection rates: 10 % for GC and 28.9% for CT IDPH STD Section: Jan – May 2009, 1,714 females tested positive for chlamydia at a family planning or SBHCs. A total of 746 (43.5%) females returned for rescreening within two to 12 months CT re-infection rate was 22.3% (166 of 746)
11
Reinfection increases risk of: Pelvic inflammatory disease Ectopic pregnancy Chronic pelvic pain Majority of post-treatment infections result from reinfection Sex partners not treated Patient resumes sex with a new partner infected with CT/GC Recommendation: Clinicians should advise clients treated for CT/GC to be retested 3 months after treatment
12
ALL PROVIDER TYPES # Tests# Pos% Pos 31-180 days % Rescreened 180-364 days % Rescreened 31-364 days % Rescreened 58,5394,3527.428.210.939.1
13
IDPH STD Section developed “Rescreening” reports using Access Reports by: Age, Ethnicity, Race, and Sex Provider type Working on reports to determine positivity rate of those rescreened RVIPP Data subcontractors Developing similar reports for each state
15
CDC Performance Measure Among female clients, the proportion of women with positive chlamydia/gonorrhea tests that are treated within 14 and 30 days of the date of specimen collection. Prompt treatment of chlamydia and gonorrhea will reduce the duration of infectiousness and further transmission of infection in the community Aimed at preventing sequelae such as pelvic inflammatory disease (PID), ectopic pregnancy and infertility
16
Treatment Rates of Female Clients with Reported CT (Excluding Chicago) 200820092010 Provider Type w/i 14 days STD Clinics 74%78%90% Family Planning 71%77%86% Other HD Clinic 70%73%90% Priv Physician 89%92%91% School Based 86%87%88% Univeristy/College99%99%99%
17
ID clinics receiving test result via mail and set them up for FAX transmittal if feasible Focus on clinics with greatest number of cases and the lowest rates Collaborate with IDHS nurse consultants and program managers for clinics with low rates Provide constructive criticism and positive feedback Develop a corrective action plan with clinics and follow up with quarterly data
19
OBJECTIVE: increase CT/GC screening at SBHCs Collaboration IDPH STD Section IDHS SBHC Program IDHS Bureau of Community Nursing Individual SBHCs Prioritized: Largest SBHCs with highest CT positivity rate
20
Teleconference/Powerpoint with SBHCs Sexual behavior data for adolescents resulting in high incidence of disease Prevalence and incidence data showing high rates of infection in adolescents Site specific CT/GC screening data: all students and female students Clinical fusion data compared to testing data Barriers Recommendations Q/A and brainstorming
21
Outcome: 41 SBHCs participated between March 2009 thru May 2010 CT Testing: Jan-Dec 2010 vs 2009 CT screening increased 28% (additional 2,099 CT tests submitted) 249 (30%) additional CT positive tests identified 36 (18%) additional GC positive tests identified
22
Future plans: Continued monitoring of site specific data Quarterly data sent to SBHCs IDHS Bureau of Nursing SBHC intervention if CT screening decreases
23
www.gytnow.org
24
Collaboration: CDC MTV Kaiser Family Foundation Planned Parenthood Federation of American April STD Awareness Month Public Information campaign targeting young people who may be uncomfortable or uncertain about asking providers for sexual health services or talking to their partners or friends about testing
27
Objective: increase CT/GC screening at JDCs Unique challenges Safety first – secure facility and movement of residents is often difficult Residents often angry and don’t want to participate County budget cuts e.g. hours for one JDC nurse cut to 10 hrs/week or 2 hrs/day JDC “buy in” – convincing JDC staff of the importance of CT screening
28
Outcome: 12 JDCs participated in teleconference calls during 2010 CT Testing: Jan – Dec 2010 vs 2009 9 JDCs provided CT screening in 2009 12 JDCs in 2010 Overall, during 2010: CT screening increased 34% (additional 449 CT tests submitted Jan-Dec 2010) 33 (28%) additional CT positive tests identified
30
National Chlamydia Coalition Grantee Four School Based Health Centers Provide free CT/GC screening at the time of male & female athletes’ pre-participation sports physicals For many students, sports physical exam may be their only visit with a provider during the year Jun-Dec 2010 CT Pos rates range: 0% - 21.8% Overall: 16 of 186 (8.6%) Study is ongoing
32
Jan – Dec 2010: CT screening at WIC Clinics and Pregnancy Testing Centers 9 Non-health department pregnancy testing ctrs CT pos rate: 5.6% to 22.2% Overall: 47 of 346 (13.6%) Local Health Dept (Many STD clinic clients are also WIC clients) 1 Pregnancy Testing Clinic: 17 of 204 (8.3%) 2 WIC Clinics: 56 of 816 (6.9%)
33
CDPH and Chicago Public Schools CT screening initiative similar to the Philadelphia initiative Future presentation at the RVIPP Chicago meeting
35
EPT law effective date: January 1, 2010 IDPH Web site (www.idph.state.il.us)www.idph.state.il.us Guidance for Illinois Health care professionals Partner information sheets Health care professional Fact Sheet IDPH provides EPT Meds: Cefixime (single prepackaged doses) Azithromycin (single prepackaged doses)
36
Emailed to LHDs - outreach to HCP regarding EPT 41 responses 23 (56%) indicated 1-5 HCP using EPT 4 (10%) indicated > 5 HCP using EPT 14 (34%) none, or uncertain how many HCP Primary concern for not using EPT was liability 17 LHD no outreach to HCP regarding EPT Lack of staff and time 24 LHD outreach to HCP regarding EPT Educational mailings, in-services, faxes, phone calls Primary recommendation for ISP to provide simplified handouts for HCP
37
Family planning (28) – 21 (75%) provide EPT; 7 (25%) no; main issue liability followed by perceived need for patient education STD (13) – 8 (62%) provide EPT; 5 (38%) no; issue is liability and lack of standing orders SBHC (16) – 16 (100%) provide EPT; 0 no Other type of clinic (35) – 12 detention centers (0 EPT); 4 pregnancy testing centers (4 EPT); 19 other - 13 provide EPT; 6 no
38
Collaborate with a LHD physician to publish EPT information in professional newsletter, e.g. Illinois State Medical Society and others Stress EPT law and reduce fears of professional liability Develop and distribute less technical partner/patient handouts
39
Richard Zimmerman IDPH STD Section 217-782-2517 richard.zimmerman@illinois.gov
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.